<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>BioScreening - organic compounds for screening</title>
<link>http://www.bioscreening.com/index/</link>
<description>Directory  of companies supplying compounds for screening</description>
<generator>BBDMS 1.0.0</generator>
<managingEditor>info@bioscreening.com (Somebody)</managingEditor>
<webMaster>info@bioscreening.com (Somebody)</webMaster>
<pubDate>Sat, 04 Jul 2009 21:57:38 -0400</pubDate>
<lastBuildDate>Sat, 04 Jul 2009 21:57:38 -0400</lastBuildDate>
<language>en</language>
<copyright>Copyright by Somebody</copyright>
<item>
<title>ClinicalTrialsArena.com - Virtual Event</title>
<link>http://www.clinicaltrialsarena.com</link>
<description>
<![CDATA[ Three streams, one platform – an unparalleled opportunity to discover techniques to speed time to market and streamline your clinical trial processes

In response to industry demand, VIBevents is proud to announce the launch of the industry’s first virtual clinical trials event which will bring together the leading decision makers within the pharma and biotech industries. ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Wed, 27 May 2009 20:39:00 -0400</pubDate>
</item>
<item>
<title>International Symposium Stem Cell Transplantation in Multiple Sclerosis: Sharing the Experience in Moscow, Russia on the 5th of October, 2009</title>
<link>http://www.bioscreening.net/2009/01/23/international-symposium-stem-cell-transplantation-in-multiple-sclerosis-sharing-the-experience-in-moscow-russia-on-the-5th-of-october-2009/</link>
<description>
<![CDATA[ The Symposium is focused on the new modality of multiple sclerosis treatment– immunosuppressive therapy followed by autologous stem cell transplantation. Centers in Europe, North and South America, Russia, China, Israel and Australia have successfully performed this procedure, and, to date, more than 600 stem cell transplantations in multiple sclerosis have been performed worldwide. ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Fri, 23 Jan 2009 22:38:00 -0500</pubDate>
</item>
<item>
<title>ZINC Database - emolecule repository</title>
<link>http://www.bioscreening.net/2009/01/12/zinc-database-emolecule-repository/</link>
<description>
<![CDATA[ What is ZINC? It is a free database of millions of commercially-available compounds for virtual screening in ready-to-dock format.
Why is it needed? Compounds that are available today can become unavailable in six months because of unavailability of the underlying reagents. For most vendors, the list of available compounds is significantly smaller than the list of […] ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Fri, 23 Jan 2009 22:37:00 -0500</pubDate>
</item>
<item>
<title>Vanderbilt University Announces Partnership with Janssen Pharmaceutica N.V. for Schizophrenia Drug Research</title>
<link>http://www.bioscreening.net/2009/01/12/vanderbilt-university-announces-partnership-with-janssen-pharmaceutica-nv-for-schizophrenia-drug-research/</link>
<description>
<![CDATA[ Vanderbilt University is pleased to announce a licensing and research agreement with Janssen Pharmaceutica N.V., focusing on discovery of novel drugs for the treatment of schizophrenia. Under the terms of the agreement Vanderbilt University grants Janssen Pharmaceutica N.V. a worldwide exclusive license to existing compounds acting on a neurotransmitter receptor target, and provides a mechanism […] ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Fri, 23 Jan 2009 22:36:00 -0500</pubDate>
</item>
<item>
<title>Cell-Based Assays: Innovations in Reagents, Technologies & Screening October 23 - 24, 2008</title>
<link>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/</link>
<description>
<![CDATA[ Cell-based assays provide one of the most valuable tools in drug discovery. They are routinely used in target validation, HTS campaigns, structure activity relationship analyses and ADMET studies. Many factors need to be considered in designing, developing and running relevant cell based assays to progress discovery programs. Significant advances continue to be made in assay […] ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Wed, 22 Oct 2008 16:58:00 -0400</pubDate>
</item>
</channel>
</rss>
